Joint Formulary & PAD

Homepage

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

Search terms include drug names, indications, brand names and keywords.

A-Z of Drugs :
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Quick Links

Please select from the links below to explore this site.

Show

Welcome to the Joint Formulary and PAD

News

Welcome to the Surrey Heartlands Joint Formulary & Prescribing Advisory Database (PAD)

Please take a moment to read the welcome article. There are a few therapeutic areas that have not yet been added to the formulary: Smoking Cessation, Vaccines These are in the process of being reviewed and will be uploaded over the next few months. For a full list of outstanding sections, please read the article by clicking the article title above. Thank you
Article published on : 07 May 2025

Frequently asked questions

Article published on : 11 Jun 2025

Levemir (insulin detemir) Penfill and FlexPen discontinuation

Levemir Penfill and FlexPen are to be discontinued. Stock likely to be exhausted by December 2026. All patients will need to be switched to an alternative insulin - see article for more information and advice.
Article published on : 11 Sep 2025

Prescribing for children / paediatrics in Primary Care

As a general rule, the BNF for Children should be used as a point of reference for indications and dosing. Provision is made within the Interface Prescribing Policy, recognising that much prescribing in paediatrics is unlicensed or off-label.
Article published on : 11 Feb 2026

Latest Additions (10)

Please select a Title from the list below to view full profile details.

Title
Traffic Light Status
Published Date
See narrative
12 Mar 2026
Denosumab - Osteoporosis
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Subcutaneous injection (sc)
Green (see narrative)
11 Mar 2026
22 Sep 2025
Non Formulary
11 Jun 2025
Melatonin - Insomnia in adults
Formulations: Capsules
Non Formulary
11 Jun 2025
Melatonin - Insomnia in adults
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Immediate release tablets
Green
11 Jun 2025
Melatonin - Insomnia in adults
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Modified release tablets
Green
11 Jun 2025
Melatonin - Insomnia in adults
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Oral solution
Green
11 Jun 2025
1
See narrative
Published Date: 12 Mar 2026
Formulations: Tablets
2
Green (see narrative)
Published Date: 11 Mar 2026
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Subcutaneous injection (sc)
3
Published Date: 06 Mar 2026
4
Published Date: 22 Sep 2025
6
Non Formulary
Published Date: 11 Jun 2025
7
Non Formulary
Published Date: 11 Jun 2025
Formulations: Capsules
8
Green
Published Date: 11 Jun 2025
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Immediate release tablets
9
Green
Published Date: 11 Jun 2025
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Modified release tablets
10
Green
Published Date: 11 Jun 2025
Status: ASPH, Primary Care, RSFT, SABP, SASH
Formulations: Oral solution